We are leaders, innovators, and scientists aiming to pursue medicines that are transformational for patients.

Executive Team

Saurabh Saha, MD, PhD

Chief Executive Officer and Director

Mario Alberto Accardi, PhD

President of the Orexin Program

Karen Anderson

Chief People Officer

Tia Bush

Chief Technology and Quality Officer

John Crowley, CPA

Chief Financial Officer

Iqbal Hussain

General Counsel and Corporate Secretary

Stephen Kanes, MD, PhD

Chief Medical Officer

Kimberly McCormick, PharmD

Senior Vice President, Regulatory Affairs and Medical Writing

Kristen Sheppard, Esq

Senior Vice President,
IR and Corporate Communications

Charlene Stoudt

Senior Vice President, Clinical Development Operations

Gregory Weinhoff, MD, MBA

Chief Business Officer

Antoine Yver, MD, MSc

Senior Advisor of Clinical Development

Board of Directors

Francesco De Rubertis, PhD

Chairman of the Board, Centessa Pharmaceuticals

Co-Founder & Partner, Medicxi

Arjun Goyal, MD, MPHIL, MBA

Mary Lynne Hedley, PhD

Senior Scientific Fellow and Strategic Advisor,
The Broad Institute of MIT and Harvard

Mathias Hukkelhoven, PhD

Former Senior Vice President, Global Regulatory, Safety & Biometrics, Bristol Myers Squibb

Samarth Kulkarni, PhD

Chief Executive Officer, CRISPR Therapeutics

Saurabh Saha, MD, PhD

Chief Executive Officer

Carol Stuckley, MBA

Former Pfizer Inc. Corporate Officer

Brett Zbar, MD

Managing Director and Global Head of Life Sciences, General Atlantic

Our mission is to discover and develop medicines that are transformational for patients.